Assessing cognitive decline using a new screening tool

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of a new screening tool called MASCoD (Multidimensional Assessment of Subjective Cognitive Decline) in detecting and monitoring subjective cognitive decline (SCD). The study will analyze the correlation between MASCoD scores and neuropsychological evaluations, as well as brain imaging using 18F-FDG-PET to predict the risk of developing severe cognitive decline. Participants will undergo cognitive training interventions to assess the potential benefits of rehabilitation in managing SCD. The study focuses on individuals who report cognitive decline without any other neurological issues.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* reported subjective cognitive decline without any other cognitive or neurological issue,
* Italian education,
* adult (\> 55 years old),
* understanding of research aims,
* signed informed consent,
* participation on a voluntary and non-payied bases.

Exclusion Criteria:

* serious clinical conditions (e.g. severe cardiac and respiratory problems, neoplasia)
* prior diagnosis of psychiatric disorders according to DSM-5,
* prior diagnosis of cognitive decline,
* relevant visuo-perceptive or hearing deficits,
* illiteracy or relapse in illiteracy,
* refusal to partake in the research.

Where it's running

• ICS Maugeri Montescano Institute
  Montescano, Pavia, Italy Recruiting

Study contacts

• Study coordinator: Cira Fundarò, Neurologist
• Email: cira.fundaro@icsmaugeri.it
• Phone: 0385247268

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• China HEAD: a large community study on healthy aging and dementia

  This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.

  Recruiting at 30 sites Fudan University · Beijing and 29 other locations · NCT07912710

• Can citicoline help prevent cognitive decline after delirium in older adults with hip fracture?

  This study tests whether taking citicoline for 6 months after discharge helps prevent cognitive decline in adults 65 and older who had delirium during hospitalization for hip fracture.

  Recruiting Phase 2 University of Milano Bicocca · Monza, Monza E Brianza · NCT07804498

• See if cognitive impairment is common in older adults admitted for non-neurological rehab

  This study tests how often cognitive impairment appears in patients aged 45 and older who are in non-neurological rehab units after hospitalization.

  Recruiting at 3 sites Fondazione Don Carlo Gnocchi ETS · Florence, FI and 2 other locations · NCT07731334

• Effects of a Multidomain Community Program on Thinking and Quality of Life for Older Adults

  This study tests whether a multidomain, community-based program can improve cognitive function and quality of life for adults aged 60 and up who are active participants at a center in Istanbul, Turkey.

  Recruiting Istanbul Medipol University Hospital · Istanbul, Bagcılar · NCT07610109

• Accelerated rTMS for Cognitive Function in adults with mild to moderate cognitive impairment

  This study tests whether a short course of accelerated rTMS with the EXOMIND device can improve thinking skills in adults ages 50–90 with mild cognitive impairment or mild dementia.

  Recruiting San Francisco Neurology and Sleep Center · San Francisco, California · NCT07547319

• Long-term walnut intake and brain function in abdominally obese adults

  This trial tests whether eating walnuts for 24 weeks improves brain blood flow and insulin sensitivity, and whether it boosts thinking and appetite control in adults with abdominal obesity.

  Recruiting Maastricht University Medical Center · Maastricht, Limburg · NCT07422220

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.